Immuneering (IMRX) EBITDA Yield: History & Chart

Immuneering Corporation(IMRX)

Biotechnology · Cambridge, MA

$3.98-0.06 (-1.49%)

Delayed quote: Oct 6, 2026, 10:55 AM EDT

About Immuneering Corporation

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development efforts are two key drug candidates: IMM-1-104, a dual-MEK inhibitor intended for the treatment of various cancers, including pancreatic, melanoma, colorectal, and non-small cell lung cancer, specifically those driven by RAS and/or RAF gene mutations. The second is IMM-6-415, which is being developed to treat solid tumors. Beyond these advanced-stage programs, Immuneering's early-stage pipeline includes five oncology initiatives aimed at components of the MAPK or mTOR signaling pathways, along with two neuroscience programs, all currently in the discovery phase. Founded in 2008, Immuneering Corporation is headquartered in Cambridge, Massachusetts. It was formerly a subsidiary of Teva Pharmaceutical Industries Limited.

Cambridge, MA

57 employees

immuneering.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Benjamin J. Zeskind

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Immuneering Corporation (IMRX)	$144.48M	N/A	N/A	N/A	N/A
Korsana Biosciences, Inc. (KRSA)vs ›	$144.00M	N/A	N/A	N/A	N/A
Nyxoah S.A. (NYXH)vs ›	$142.60M	N/A	N/A	N/A	N/A
Acumen Pharmaceuticals, Inc. (ABOS)vs ›	$150.23M	N/A	N/A	N/A	N/A
NervGen Pharma Corp. Common stock (NGEN)vs ›	$147.13M	N/A	N/A	N/A	N/A
LifeMD, Inc. (LFMDP)vs ›	$147.97M	N/A	0.81%	0.81%	0.81%
AirSculpt Technologies, Inc. (AIRS)vs ›	$142.15M	0.22%	0.33%	3.24%	2.95%
Fortress Biotech, Inc. (FBIOP)vs ›	$139.73M	N/A	N/A	N/A	N/A
Alpha Cognition Inc (ACOG)vs ›	$139.63M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$151.01M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

Immuneering Corporation (IMRX)

$144.48M

N/A

Korsana Biosciences, Inc. (KRSA)vs ›

$144.00M

N/A

Nyxoah S.A. (NYXH)vs ›

$142.60M

N/A

Acumen Pharmaceuticals, Inc. (ABOS)vs ›

$150.23M

N/A

NervGen Pharma Corp. Common stock (NGEN)vs ›

$147.13M

N/A

LifeMD, Inc. (LFMDP)vs ›

$147.97M

N/A

0.81%

AirSculpt Technologies, Inc. (AIRS)vs ›

$142.15M

0.22%

0.33%

3.24%

2.95%

Fortress Biotech, Inc. (FBIOP)vs ›

$139.73M

N/A

Alpha Cognition Inc (ACOG)vs ›

$139.63M

N/A

Cardiol Therapeutics Inc. (CRDL)vs ›

$151.01M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

IMRX EBITDA Yield Metrics

IMRX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics